Target intelligence / Profile preview

RNA, Ro60-associated Y1 (RNY1)

Target
RNY1
Molecular classification
Other, Noncoding RNA, small cytoplasmic Y RNA
01

Overview

RNA, Ro60-associated Y1 (RNY1) is a small cytoplasmic noncoding RNA that forms part of the Ro ribonucleoprotein (Ro RNP) complex by tightly associating with the Ro60 protein and other partners[1][2][7]. RNY1 is evolutionarily conserved and is crucial for the structural assembly and function of Ro RNPs. It plays diverse roles such as regulating the subcellular localization of Ro60, scaffolding interactions with effector proteins, and influencing RNA quality control and degradation pathways[1][3]. RNY1 is not a traditional therapeutic target, but its complex (Ro RNP) is a major autoantigen recognized by autoantibodies in systemic lupus erythematosus and Sjögren syndrome, making the RNP complex clinically significant in autoimmunity[1][7]. Four human Y RNAs are known (Y1, Y3, Y4, and Y5), with Y1/RNY1 often functioning distinctly by recruiting or scaffolding various RNA-binding proteins[3][4]. Its structure features a conserved stem for Ro60 binding and additional modules that regulate protein partnerships and subcellular localization[1][3]. Direct pharmacological targeting of RNY1 itself is not currently described.

Other names
hY1HY1Y1RNA, Ro-associated Y1RNA, Y1 small cytoplasmic (associated with Ro protein)RNY1
02

Biological functions

Formation of Ro ribonucleoprotein complexesRegulation of RNA quality controlScaffolding for ribonucleoprotein assembly
03

Disease associations

Autoimmune disease
04

Biomarkers

Detection in Ro/SSA autoantibody assays

Beyond the preview

Go deeper on RNA, Ro60-associated Y1 (RNY1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, Ro60-associated Y1 (RNY1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call